Analysis of monocyte and lymphocyte counts of TBDC patients taking anti-TBC drugs

Authors

  • Eka Susanti Department of Medical Laboratory Technology, Politeknik Kesehatan Kementerian Kesehatan Pontianak, Pontianak, West Kalimantan, Indonesia
  • Sugiono Sugiono Department of Medical Laboratory Technology, Politeknik Kesehatan Kementerian Kesehatan Pontianak, Pontianak, West Kalimantan, Indonesia
  • Laila Kamilla Department of Medical Laboratory Technology, Politeknik Kesehatan Kementerian Kesehatan Pontianak, Pontianak, West Kalimantan, Indonesia

DOI:

https://doi.org/10.53770/electron.v7i1.514

Keywords:

TB, Monocytes, Lifocytes

Abstract

Tuberculosis (TB) is an infectious disease caused by Mycobacterium tuberculosis that attacks the lungs and spreads through the air. Monocytes and lymphocytes play an important role in the immune response to TB. Changes in their numbers can reflect the immune response and treatment effectiveness. Monitoring patients during treatment provides insight into disease progression and therapy response. This study aims to analyze the number of monocytes and lymphocytes in TB patients taking anti-tuberculosis drugs at Puskesmas Ledo, Bengkayang Regency. The study was descriptive quantitative to describe the number of monocytes and lymphocytes. The population was all TB patients undergoing treatment in the working area of Puskesmas Ledo, with total sampling technique and the number of respondents as many as 30 people. From the results of the study, 21 respondents had high monocyte counts: 8 in the early phase of treatment and 13 in the advanced phase. Meanwhile, 9 respondents had non-high monocyte counts, consisting of 4 in the initial phase and 5 in the continuation phase. Of the total respondents, 3 people had high lymphocyte counts, namely 2 in the initial phase and 1 in the continuation phase, while 27 had non-high lymphocyte counts, consisting of 10 in the initial phase and 17 in the continuation phase. In conclusion, high monocyte counts were more common in the continuation phase (61.9%), while high lymphocyte counts were more common in the early phase (66.7%).

References

Alfaiza, S. N., & Wuryaningsih, C. E. (2022). Pelaksanaan Program Directly Observed Treatment Short-Course (DOTS) Selama Pandemi COVID-19 di Wilayah Puskesmas Depok Jaya. Perilaku dan Promosi Kesehatan: Indonesian Journal of Health Promotion and Behavior, 4(2), 58-71. https://doi.org/10.47034/ppk.v4i2.6345

Banuls, A. L., Sanou, A., Van Anh, N. T., & Godreuil, S. (2015). Mycobacterium tuberculosis: ecology and evolution of a human bacterium. Journal of medical microbiology, 64(11), 1261-1269. https://doi.org/10.1099/jmm.0.000171

Chai, Q., Zhang, Y., & Liu, C. H. (2018). Mycobacterium tuberculosis: an adaptable pathogen associated with multiple human diseases. Frontiers in cellular and infection microbiology, 8, 158. https://doi.org/10.3389/fcimb.2018.00158

Chedid, C., Kokhreidze, E., Tukvadze, N., Uddin, M., Biswas, S., Russomando, G., & Hoffman, J. (2020). Association of Baseline White Blood Cell Counts With Tuberculosis Treatment Outcome: A Prospective Multicentered Cohort Study. International Journal of Infectious Diseases, 100, 199–206. https://doi.org/10.1016/j.ijid.2020.09.017

Delogu, G., Sali, M., & Fadda, G. (2013). The biology of mycobacterium tuberculosis infection. Mediterranean journal of hematology and infectious diseases, 5(1), e2013070. https://doi.org/10.4084/MJHID.2013.070

Gagneux, S. (2018). Ecology and evolution of Mycobacterium tuberculosis. Nature Reviews Microbiology, 16(4), 202-213. https://doi.org/10.1038/nrmicro.2018.8

Kadarwati, A., Sukeksi, A., & Putri, G. S. A. (2023). Hubungan Jumlah Monosit Dan Nilai Laju Endap Darah (LED) Terhadap Lama Pengobatan Pasien Tuberculosis: Correlation Of Monocyte Number And Erythrocyte Sedimentation Rate (Esr) Value Against To Duration Of Treatment In Tuberculosis Patients. Borneo Journal of Medical Laboratory Technology, 6(1), 394-399. https://doi.org/10.33084/bjmlt.v6i1.6077

Kementerian Kesehatan Republik Indonesia. (2023). Laporan Program Penanggulangan Tuberkulosis Tahun 2022. Jakarta: Kementerian Kesehatan Republik Indonesia

Mishra, S., Gala, J., & Chacko, J. (2024). Factors affecting mortality in critically ill patients with tuberculosis: A systematic review and Meta-Analysis. Critical care medicine, 52(6), e304-e313. https://doi.org/10.1097/ccm.0000000000006226

Miggiano, R., Rizzi, M., & Ferraris, D. M. (2020). Mycobacterium tuberculosis pathogenesis, infection prevention and treatment. Pathogens, 9(5), 385. https://doi.org/10.3390/pathogens9050385

Mulya, F. (2023). Analisis Program Penanggulangan TBC di Indonesia dalam Upaya Pencapaian Target Eliminasi TBC Tahun 2030. Universitas Indonesia.

Nabilah, R., Sangging, P. R. A., & Wulan, A. J. (2023). Hubungan antara Kejadian Tuberkulosis Ekstra Paru dengan Kadar Limfosit dan Monosit di RSUD Dr. H. Abdul Moeloek Provinsi Lampung periode Januari 2018-Desember 2019. Medical Profession Journal of Lampung, 13(5), 768-777.

Putra, T. F. (2020). Perbedaan Hitung Jenis Leukosit Pada Penderita Tuberkulosis Paru Sebelum Dan Sesudah Pengobatan Dengan Obat Anti Tuberkulosis Selama 3 Bulan Di RSUD Arifin Ahmad Pekanbaru. Sekolah Tinggi Ilmu Kesehatan Perintis Padang.

Riefani, S. (2024). Vitamin D, Body Mass Index, And Total Lymphocyte Count In Drug- Sensitive And Drug-Resistant Tuberculosis Patients In Banjarmasin. Jurnal Respirasi, 10(1), 14–22. https://doi.org/10.20473/jr.v10-i.1.2024.14-22

Ritonga, N. (2020). Pemeriksaan Jumlah Sel Monosit Pada Penderita Tuberculosis Paru. Karya Tulis Ilmiah. Medan: Poltekkes Kemenkes Medan.

Sugiyono. (2019). Metodologi Penelitian Kuantitatif, Kualitatif, dan R&D. Bandung: Alfabheta.

Susilawati, N., & Octrisdey, K. (2023). Prevalensi Penderita Tuberkulosis Paru Di Puskesmas Oekabiti Kecamatan Amarasi Kabupaten Kupang Periode 2017-2020. Jurnal Kesehatan Dan Kedokteran, 2(1), 49–53. https://doi.org/10.56127/jukeke.v2i1.538

Vajapey, S., & Horn, A. (2021). Tuberculosis of the extra-axial skeleton in paediatric patients. SA Orthopaedic Journal, 20(1), 21-26. https://doi.org/10.17159/2309-8309/2021/v20n1a2

WHO. (2020). Global Tuberculosis Report 2020. Geneva: World Health Organization

Wondmagegn, T., Damtie, D., Genetu, M., Biadgo, B., Lemma, M., & Negash, M. (2020). T lymphocyte subpopulations and intestinal helminthes profile among tuberculosis patients co-infected with HIV before and after anti tubercular treatment at University of Gondar Hospital, Northwest Ethiopia. BMC Infectious Diseases, 20(1), 109. https://doi.org/10.1186/s12879-020-4845-y

Downloads

Published

2025-01-31

How to Cite

Susanti, E., Sugiono, S., & Kamilla, L. (2025). Analysis of monocyte and lymphocyte counts of TBDC patients taking anti-TBC drugs . ELECTRON (Journal of Science and Technology), 7(1), 1–8. https://doi.org/10.53770/electron.v7i1.514